IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
3D-Quantitative Structure Activity Relationship Study of Pyrazolothiazol-4-(5H)-One Derivatives as Epidermal Growth Factor Receptor Inhibitors

Author: DEEAPLI JAGDALE, MAHESH KHARATMOL, PRIYANAKA GANDHI, PRIYANKA GAIKWAD, NEHA NANDEDKAR
Abstract: Pyrazolothiazol-4-(5H)-one derivatives were synthesized and studied for in vitro anti-cancer activity on cell line MCF-7 which is known to over-express epidermal growth factor receptor (EGFR). EGFR is considered as a good target for chemotherapeutic intervention. Three-dimensional quantitative structure activity relationship (3D-QSAR) approach became very useful and largely widespread technique for ligand-based drug design. In this paper, an attempt was made to develop a 3D-QSAR study on a series of pyrazolothiazol-4-(5H)-one derivatives acting as protein tyrosine kinase (EGFR) inhibitors. The study has been carried out using VLife MDS 4.6.1 software. The stepwise 3D-QSAR kNN-MFA method was applied to derive QSAR model. The information rendered by 3D-QSAR model may lead to a better understanding and designing of novel EGFR inhibitor molecules. 3D-QSAR is an important tool in understanding the structural requirements for design of novel, potent and selective EGFR inhibitors. Thus, the present work can be employed for new drug discovery and can be used in future for designing novel derivatives of pyrazolothiazol-4-(5H)-one with higher EGFR inhibitory activity.
Keyword: EGFR inhibitors, stepwise 3D-QSAR, kNN-MFA model, pyrazolothiazol-4-(5H)-one derivatives.
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free